Navigation Links
Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder
Date:7/15/2008

Owing to Safety, Escitalopram Will Remain as the Clinical Gold Standard

Treatment, According to a New Report from Decision Resources

WALTHAM, Mass., July 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's long-term efficacy in preventing recurrence of depressive mood episodes in patients who suffer from major depressive disorder, is the attribute that most influences psychiatrists' prescribing decisions in the treatment of this disorder. Clinical data and expert opinion show that current and emerging therapies will continue to struggle for patient share through subtle differences in efficacy, tolerability and delivery.

The new report entitled Major Depressive Disorder: Long-Term Efficacy Would Differentiate a New Drug in the Crowded Antidepressant Market finds that if an agent preventing recurrence of depressive mood episodes superior to that of sales-leading Wyeth's Effexor XR were to be launched, it would earn a 25 percent patient share, according to surveyed psychiatrists. The report also finds that although Effexor XR is the sales leader in the major depressive disorder drug market, the current and future Decision Resources proprietary clinical gold standard treatment for the indication is escitalopram (Lundbeck's Cipralex/Seroplex; Forest's Lexapro).

Although escitalopram's efficacy is not the highest in our study, the drug outscored any other current therapy in the area of safety. Experts we interviewed explain that because the drug is an active metabolite, lower doses can be used, an advantage that results in safety benefits.

"Based on available data and expert opinion, we do not expect any therapy under development to displace escitalopram as the clinical gold standard for major depressive disorder," said Carlos Dedesma, Ph.D., analyst at Decision Resources. "Although some therapies in development hold pr
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
2. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
3. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
4. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
5. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
6. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
7. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
10. Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service
11. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 24, 2014 /PRNewswire/ - Milestone Pharmaceuticals, Inc. today announced ... Melbourne, Australia of MSP-2017, ... treatment of paroxysmal supraventricular tachycardia (PSVT).  The results ... well tolerated at single doses up to and ... desirable PK properties including rapid onset, and validating ...
(Date:11/24/2014)... Nov. 24, 2014 The Female Health Company ... investor conference call to discuss its operating results for ... 2014 on Tuesday, December 2, 2014 at 11:00 a.m. ... its operating results earlier the same day. ... conference call by dialing 1-877-374-8416 (international participants dial 1-412-317-6716) ...
(Date:11/24/2014)... 24, 2014  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... from the board of directors and from his positions as ... most recently serving as the company,s president and chief operating ... join the board of directors.  Gary Lyons , a ... chairman. Mr. Gower is expected to remain an employee until ...
Breaking Medicine Technology:Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3The Female Health Company To Report FY2014 Operating Results on Tuesday, December 2, 2014 2Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3
... , , ROYAL OAK, ... and business security company today announced the exclusive ... look like a piece of jewelry, these personal emergency ... response assistance. , (Photo: http://www.newscom.com/cgi-bin/prnh/20091202/DE19790 ) , ...
... , WESTON, Fla., Dec. 2 American Scientific Resources ... Plus(TM), the world,s only FDA approved home needle destruction device (NDD), ... designed to fill the current demand for home injection prescription drug ... SB 486 which requires Californian,s to safely dispose of their ...
Cached Medicine Technology:World's Only FDA Approved Home Needle Destruction Device is in Production 2World's Only FDA Approved Home Needle Destruction Device is in Production 3
(Date:11/24/2014)... "My friend was killed when a ... the street in his motorized wheelchair," said an inventor ... came up with this idea so that people in ... developed the Safety Lites to make a wheelchair highly ... device ensures that motorists can see the wheelchair. This ...
(Date:11/23/2014)... November 23, 2014 The report, ... 2006 to 2020 - Asia-Pacific” provides quantitative analysis ... market segments: minimally invasive body contouring devices, non-invasive ... analysis includes market size data by revenue and ... following countries: China, Japan, South Korea, Australia and ...
(Date:11/23/2014)... 2014 (HealthDay News) -- Close friends have more influence ... does, a new study says. "We,ve known ... an influence on individual alcohol use, but there are ... group and the friend group,s influence on those decisions," ... of Public Health, said in a university news release. ...
(Date:11/23/2014)... To show thanks to new and old ... white evening dresses for weddings. Customers who need ... iFitDress.com is a distinguished dress manufacturer, and it is among ... customers for a very long time. The CEO of this ... will be able to buy not only a beautiful dress, ...
(Date:11/23/2014)... Beach, CA (PRWEB) November 23, 2014 ... of American Medical Aesthetics & Wellness was recently ... Asher Milgrom, Ph.D. is president and CEO of American ... Dr. Asher Milgrom received a full scholarship to ... and the Medical School at the University of Chicago, ...
Breaking Medicine News(10 mins):Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Close Friends May Be Key to Teens' Drinking 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4
... nine peacocks found dead near a farm at K ... special team from the department was deputed to hold ... Post mortem was conducted on the dead birds, but ... Tests were parallely conducted on the residents, migratory and ...
... Institutes of Health's (NIH) National Institute of Mental Health ... linked to impulsive violence appears// to weaken brain circuits ... ,It was studied through brain scans that ... especially males – tended to have relatively smaller emotion-related ...
... official of Delhi said that the killer disease meningococcal meningitis ... // leaving another 486 affected by it. ,'So ... of meningitis, of which 18 cases have been confirmed,' said ... ,'One person succumbed to the disease Monday and the patient ...
... has thrown Europe’s poultry industry into doldrums. An urgent call ... to provide succor to the struggling poultry producers. The Union ... fearful consumers. , ,The EU's executive branch would ... almost half, to prop up the prices of poultry, that ...
... based drug firm that had manufactured TGN-1412, has now ... tested on monkeys. Four out of the six who ... London based hospital following the drug administration are recovering, ... trial had been conducted at Northwick Park Hospital in ...
... reports of nine more cases of the deadly H5N1 strain ... given// by the country's veterinary authorities, two days after nine ... states that the ducks were found in the South of ... of Aeroe. ,Authorities in Denmark also confirmed that ...
Cached Medicine News:Health News:A gene related to aggression weakens the brain 2Health News:Delhi Witnessed 34 Meningitis Deaths In Three Months 2Health News:Drug Company Admits Knowledge Of Side Effects In Monkeys 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: